Task Force 11: Additional Cardiac Conditions and Considerations in Competitive Athletes.
Researchers
Jeffrey J Hsu, Aaron L Baggish, Katherine E Economy, Michael S Emery, Mark S Link, Tamanna Singh, Katie M Stewart, Benjamin D Levine, Jonathan H Kim, Andre Lagerche
Abstract
The recently updated AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Abnormalities provides a comprehensive framework for guiding clinicians in the evaluation and management of competitive athletes. Divided into 11 Task Forces, it covers a broad range of cardiovascular diseases and clinical scenarios. Task Force 11 was devoted to cardiac conditions and considerations in athletes not included in the other Task Forces. Here, we present the detailed rationale for the clinical considerations covered in this section of the Scientific Statement. These topics include hypertension, commotio cordis, pulmonary embolism, performance-enhancing drugs and supplements, exercise in extreme environments (specifically altitude and scuba diving), and pregnancy.Source: PubMed (PMID: 43024820)View Original on PubMed